Comments on ‘Long-term outcomes of phakic patients with diabetic macular oedema treated with intravitreal fluocinolone acetonide (FAc) implants’ – (Eye 30, 1023 (July 2016))
Comments on ‘Long-term outcomes of phakic patients with diabetic macular oedema treated with intravitreal fluocinolone acetonide (FAc) implants’ Eye 30, 1023 (July 2016). doi:10.1038/eye.2016.27 Authors: B Takkar & S Azad
Reply to ‘Comments on Long-term outcomes of phakic patients with diabetic macular oedema treated with intravitreal fluocinolone acetonide (FAc) implants’ – (Eye 30, 1023 (July 2016))
Reply to ‘Comments on Long-term outcomes of phakic patients with diabetic macular oedema treated with intravitreal fluocinolone acetonide (FAc) implants’ Eye 30, 1023 (July 2016). doi:10.1038/eye.2016.33 Authors: Y Yang, C Bailey, F G Holz, N Eter, M Weber, C Baker, S Kiss, U Menchini, J M Ruiz Moreno, P Dugel & A Lotery
Treatment trials for diabetic macular oedema – (Eye 30, 1024 (July 2016))
Treatment trials for diabetic macular oedema Eye 30, 1024 (July 2016). doi:10.1038/eye.2016.40 Author: D McLeod
Myopic traction maculopathy – (Eye 30, 1025 (July 2016))
Myopic traction maculopathy Eye 30, 1025 (July 2016). doi:10.1038/eye.2016.38 Author: G Panozzo
Combination of peripheral laser photocoagulation with intravitreal bevacizumab in naïve eyes with macular edema secondary to CRVO: prospective randomized study – (Eye 30, 1025 (July 2016))
Combination of peripheral laser photocoagulation with intravitreal bevacizumab in naïve eyes with macular edema secondary to CRVO: prospective randomized study Eye 30, 1025 (July 2016). doi:10.1038/eye.2016.51 Authors: J Chhablani, R Narayanan, A Mathai & M Tyagi